Clinical Trial Update: A Study of Adavosertib (MK-1775) in Combination With Topotecan/Cisplatin in Participants With Cervical Cancer (MK-1775-008) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on adavosertib (MK-1775) with topotecan/cisplatin in cervical cancer, a Phase 1/2 study that has terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Adavosertib (adavosertib)
• CISPLATIN (cisplatin)
• Topotecan (topotecan)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-12-14